Synapse - Center for Pancreatic Cancer Research

Results (8394)

Clonality analysis of synchronous endometrial and ovarian carcinomas in patients with Lynch syndrome

Meeting Abstract

Moukarzel, L.; Da Cruz Paula, A.; Hoang, T.; Sebastiao, A. P.; Pareja, F.; Park, K.; Jungbluth, A.; Capella, G.; Pineda, M.; Reis-Filho, J.; more...
International Journal of Gynecological Cancer (2019)

Fulltext@MSK | Save

Synthesis, preclinical analysis, and first-in-human phase I imaging of 89Zr-DFO-daratumumab for CD38 targeted imaging of myeloma

Meeting Abstract

Ulaner, G.; Sobol, N.; O'Donoghue, J.; Lyashchenko, S.; Lewis, J.; Landgren, C. O.
Clinical Lymphoma, Myeloma and Leukemia (2019)

Fulltext@MSK | Save

POLO: Time to treatment discontinuation and subsequent therapies following maintenance olaparib for patients (pts) with a germline BRCA mutation and metastatic pancreatic cancer (mPC)

Meeting Abstract

Van Cutsem, E.; Golan, T.; Hammel, P.; Reni, M.; Macarulla, T.; Hall, M. J.; Park, J. O.; Hochhauser, D.; Arnold, D.; Oh, D. Y.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

POLO: Health-related quality of life (HRQoL) of olaparib maintenance treatment versus placebo in patients with a germline BRCA mutation and metastatic pancreatic cancer (mPC)

Meeting Abstract

Hammel, P.; Kindler, H. L.; Reni, M.; Van Cutsem, E.; Mercade, T. M.; Hall, M. J.; Park, J. O.; Hochhauser, D.; Arnold, D.; Oh, D. Y.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

Clinicopathological and molecular criteria assessment for the screening of hypermutated proficient mismatch repair (pMMR) colorectal cancers (CRC) with exonucleasic domain POLE (edPOLE) mutations (mt)

Meeting Abstract

Rousseau, B. J. C.; Cohen, J.; Calderaro, J.; Dupuy, A.; Bourgoin, R.; Tournigand, C.; Baumgaertner, I.; Ropert, S.; Thirot Bidault, A.; Klotz, C.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

Phase III, international, multicenter, randomized, open-label trial of adjuvant nab-paclitaxel plus gemcitabine (nab-P/G) vs gemcitabine (G) alone for surgically resected pancreatic adenocarcinoma (APACT): Subgroup analyses

Meeting Abstract

Tempero, M. A.; Reni, M.; Riess, H.; O'Reilly, E. M.; Krishnamurthi, S.; Österlund, P.; Ales-Diaz, I. C.; Milella, M.; Siena, S.; Tabernero, J.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

A phase II basket study of MCLA-128, a bispecific antibody targeting the HER3 pathway, in NRG1 fusion-positive advanced solid tumours

Meeting Abstract

Schram, A. M.; Drilon, A.; Macarulla Mercade, T.; O'Reilly, E. M.; Rodon, J. A.; Wolpin, B. M.; Ou, S. H. I.; Kim, D. W.; Yang, J. C. H.; Lam, Y. C. J.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

A randomized phase II study of peri-operative ipilimumab, nivolumab and cryoablation versus standard care in women with residual, early stage/resectable, triple negative breast cancer after standard-of-care neoadjuvant chemotherapy

Meeting Abstract

McArthur, H. L.; Comen, E. A.; Bryce, Y.; Solomon, S. B.; Leal, J. H. S.; Rodine, M.; Abaya, C. D.; Patil, S.; Page, D. B.; Norton, L.
Annals of Oncology (2019)

Fulltext@MSK | Save

First-line pembrolizumab (P), trastuzumab (T), capecitabine (C) and oxaliplatin (O) in HER2-positive metastatic esophagogastric adenocarcinoma

Meeting Abstract

Janjigian, Y. Y.; Maron, S.; Chou, J. F.; Gabler, A. R.; Simmons, M. Z.; Momtaz, P.; Shcherba, M.; Ku, G. Y.; Won, E.; Sanchez-Vega, F.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save

Pembrolizumab in microsatellite instability high cancers: Updated analysis of the phase II KEYNOTE-164 and KEYNOTE-158 studies

Meeting Abstract

Diaz, L. A.; Le, D.; Maio, M.; Ascierto, P. A.; Geva, R.; Motola-Kuba, D.; André, T.; Van Cutsem, E.; Gottfried, M.; Elez, E.; more...
Annals of Oncology (2019)

Fulltext@MSK | Save